Lorenzo Melchor

3.4k citations
39 papers · 1.6k indexed · h-index 20
  • Hematology top 1%
    • Multiple Myeloma Research and Treatments 13
    • Cancer Genomics and Diagnostics 15
  • Oncology top 5%
    • Cancer Cells and Metastasis 4
    • Cancer Treatment and Pharmacology 3
    • Cancer-related Molecular Pathways 3
    • Protein Degradation and Inhibitors 7
  • Genetics top 10%
    • BRCA gene mutations in cancer 8
    • Genomic variations and chromosomal abnormalities 8

Lorenzo Melchor

37 papers receiving 1.6k citations

Peers

Lorenzo Melchor
Comparison fields: 5 of 97
  • Hematology 707
  • Cancer Research 399
  • Oncology 538
  • Molecular Biology 1.1k
  • Genetics 110
Replace Christopher P. Wardell with:
Christopher P. Wardell United Kingdom
Loris Bernard Italy
Ian Titley United Kingdom
Helena Kempski United Kingdom
Victoria M. Garbitt United States
Anne Estreicher Switzerland
Letha A. Phillips United States
B. Douglas Smith United States
Friedrich W. Cremer Germany
David González de Castro United Kingdom
Lorenzo Melchor relative to Christopher P. Wardell United Kingdom Christopher P. Wardell's profile →
Citations per field
00.5×1.5×
Christopher P. Wardell · 1×
Citations per year

Countries citing papers authored by Lorenzo Melchor

Since Specialization
Citations

This map shows the geographic impact of Lorenzo Melchor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorenzo Melchor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorenzo Melchor more than expected).

Fields of papers citing papers by Lorenzo Melchor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorenzo Melchor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorenzo Melchor. The network helps show where Lorenzo Melchor may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lorenzo Melchor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lorenzo Melchor Line = papers co-authored together Lorenzo Melchor links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20213
2 20203
3 20175
4 201692
5 201511
6 201412
7 2014169
8 201395
9 2013204
10 200977
11 200839
12 20086
13 200728
14 200741
15 200762
16 200629
17 200629
18 200515
19 20054
20 200436

About Lorenzo Melchor

Lorenzo Melchor is a scholar working on Hematology, Cancer Research and Genetics, having authored 39 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (15 papers), Multiple Myeloma Research and Treatments (13 papers), BRCA gene mutations in cancer (8 papers), Genomic variations and chromosomal abnormalities (8 papers), Protein Degradation and Inhibitors (7 papers), Cancer Cells and Metastasis (4 papers), Cancer Treatment and Pharmacology (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Hematology (707 citations), Cancer Research (399 citations) and Oncology (538 citations). Lorenzo Melchor has collaborated with scholars based in United Kingdom, Spain and United States. Frequent co-authors include Javier Benı́tez, Gareth J. Morgan, Annamaria Brioli, Faith E. Davies, Brian A. Walker, Christopher P. Wardell, Martin Kaiser, Michèle Cavo, Emiliano Honrado and David C. Johnson. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026